[{"Assets_0_Q2_USD":178610000.0,"CommonStockSharesOutstanding_0_Q2_shares":2044999.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-13880000.0,"NetIncomeLoss_1_Q2_USD":-9433000.0,"NetIncomeLoss_2_Q2_USD":-14633000.0,"StockholdersEquity_0_Q2_USD":-65978000.0,"Ticker":"MORF","CIK":"1679363","name":"MORPHIC HOLDING, INC.","OfficialName":"Morphic Holding Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1330068663.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190813"}]